» Articles » PMID: 36451925

Risk Factors and Clinical Effects of Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The number of trans-catheter aortic valve replacement (TAVR) procedure is increasing; However, the incidence of leaflet thrombosis is higher in TAVR than in surgical aortic valve replacement (SAVR). In this study, the risk factors for leaflet thrombosis after TAVR and its effects on hemodynamics and clinical course were investigated.

Methods And Results: Multidetector computed tomography (MDCT) was performed at 1year after TAVR in 94 patients from January 2015 to October 2020 at Samsung Medical Center in South Korea. Among the 94 patients, subclinical leaflet thrombosis occurred in 20 patients, and risk factors were analyzed. In addition, the difference in aortic valve (AV) hemodynamics between the two groups was examined and clinical outcomes compared. Indexed mean sinus of Valsalva (SOV) diameter, AV calcium volume, and post-procedure effective orifice area (EOA) were predictive of subclinical leaflet thrombosis with the area under the curve (AUC) value of 0.670 (-value = 0.020), 0.695 (-value = 0.013), and 0.665 (-value = 0.031), respectively. In echocardiography performed at the time of follow-up CT, the value of AV max velocity and AV mean pressure gradient were higher in the thrombosis group and the EOA and Doppler velocity index values were lower in the thrombosis group than in the no thrombosis group. Clinical outcome was not significantly different between the two groups (log-rank -value = 0.26).

Conclusion: Larger indexed SOV diameter, higher AV calcium volume, and smaller post-procedure AV EOA were risk factors for subclinical leaflet thrombosis after TAVR. Subclinical leaflet thrombosis has a benign course when properly managed.

Citing Articles

Incremental prognostic value of intensity-weighted regional calcification scoring using contrast CT imaging in TAVR.

Abdelkhalek M, Bahadormanesh N, Ganame J, Keshavarz-Motamed Z Eur Heart J Imaging Methods Pract. 2024; 1(2):qyad027.

PMID: 39045072 PMC: 11195730. DOI: 10.1093/ehjimp/qyad027.


Mild Paravalvular Leak May Pose an Increased Thrombogenic Risk in Transcatheter Aortic Valve Replacement (TAVR) Patients-Insights from Patient Specific In Vitro and In Silico Studies.

Kovarovic B, Rotman O, Parikh P, Slepian M, Bluestein D Bioengineering (Basel). 2023; 10(2).

PMID: 36829682 PMC: 9952825. DOI: 10.3390/bioengineering10020188.

References
1.
Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

2.
Rodes-Cabau J, Masson J, Welsh R, Garcia Del Blanco B, Pelletier M, Webb J . Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation).... JACC Cardiovasc Interv. 2017; 10(13):1357-1365. DOI: 10.1016/j.jcin.2017.04.014. View

3.
Makkar R, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D . Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. J Am Coll Cardiol. 2020; 75(24):3003-3015. DOI: 10.1016/j.jacc.2020.04.043. View

4.
Devereux R, de Simone G, Arnett D, Best L, Boerwinkle E, Howard B . Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol. 2012; 110(8):1189-94. PMC: 3462295. DOI: 10.1016/j.amjcard.2012.05.063. View

5.
Ternacle J, Pibarot P, Herrmann H, Kodali S, Leipsic J, Blanke P . Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. JACC Cardiovasc Interv. 2021; 14(13):1466-1477. DOI: 10.1016/j.jcin.2021.03.069. View